Genome-wide analysis of noncoding regulatory mutations in cancer

Weinhold, Nils, Jacobsen, Anders, Schultz, Nikolaus, Sander, Chris, Lee, William·2014·Nature Genetics
DOI 10.1038/ng.3101

Cited by (486)

Items 201–300 of 486

  1. Computational methods for cancer driver discovery: A survey
    Vu Pham, Lin Liu, Cameron P. Bracken, Gregory J. Goodall, Jiuyong Li, Thuc Duy Le · 2021 · Theranostics
  2. Transcription Factors Involved in Tumorigenesis Are Over-Represented in Mutated Active DNA-Binding Sites in Neuroblastoma
    Mario Capasso, Vito Alessandro Lasorsa, Flora Cimmino, Marianna Avitabile, Sueva Cantalupo, Annalaura Montella, Biagio De Angelis, Martina Morini, Carmen de Torres, Aurora Castellano et al. · 2019 · Cancer Research
  3. Detecting recurrent passenger mutations in melanoma by targeted UV damage sequencing
    Kathiresan Selvam, Smitha Sivapragasam, Gregory M.K. Poon, John J. Wyrick · 2023 · Nature Communications
  4. Strong Components of Epigenetic Memory in Cultured Human Fibroblasts Related to Site of Origin and Donor Age
    Nikolay A. Ivanov, Ran Tao, Josh G. Chenoweth, Anna C. Brandtjen, Michelle I. Mighdoll, John D. Genova, Ronald D.G. McKay, Yankai Jia, Daniel R. Weinberger, Joel E. Kleinman et al. · 2016 · PLoS Genetics
  5. Telomerase reverse transcriptase promoter alterations across cancer types as detected by next‐generation sequencing: A clinical and molecular analysis of 423 patients
    Maria Clemence Schwaederle, Nithya Krishnamurthy, Gregory A. Daniels, David Eric Piccioni, Santosh Kesari, Paul Timothy Fanta, Richard B. Schwab, Sandip Pravin Patel, Barbara A. Parker, Razelle Kurzrock · 2017 · Cancer
  6. PLEKHS1 Over-Expression is Associated with Metastases and Poor Outcomes in Papillary Thyroid Carcinoma
    Xiangling Xing, Ninni Mu, Xiaotian Yuan, Na Wang, C. Christofer Juhlin, Klas Strååt, Catharina Larsson, Dawei Xu · 2020 · Cancers
  7. Non-Coding Variants in Cancer: Mechanistic Insights and Clinical Potential for Personalized Medicine
    Marios Lange, Rodiola Begolli, Antonis Giakountis · 2021 · Non-Coding RNA
  8. Patterns of structural variation define prostate cancer across disease states
    Meng Zhou, Minjeong Ko, Anna C. H. Hoge, Kelsey Luu, Yuzhen Liu, Magdalena L Russell, William W. Hannon, Zhenwei Zhang, Jian Carrot‐Zhang, Rameen Beroukhim et al. · 2022 · JCI Insight
  9. Systematic Screening of Promoter Regions Pinpoints Functional Cis -Regulatory Mutations in a Cutaneous Melanoma Genome
    Rebecca C. Poulos, Julie A.I. Thoms, Anushi Shah, Dominik Beck, John E. Pimanda, Jason W.H. Wong · 2015 · Molecular Cancer Research
  10. Telomerase: The Devil Inside
    Mukesh Kumar, André Lechel, Çagatay Güneş · 2016 · Genes
  11. Hepatocellular malignant neoplasm, NOS : a clinicopathological study of 11 cases from a single institution
    Shengmei Zhou, Rajkumar Venkatramani, Shveta Gupta, Kasper S. Wang, James E. Stein, Larry L. Wang, Leo Mascarenhas · 2017 · Histopathology
  12. Identification of Single Nucleotide Non-coding Driver Mutations in Cancer
    K. Gan, Sebastian Carrasco Pro, J. Sewell, J. F. Fuxman Bass · 2018 · Frontiers in Genetics
  13. RAIN Is a Novel Enhancer-Associated lncRNA That Controls RUNX2 Expression and Promotes Breast and Thyroid Cancer
    Teresa Rossi, Mariaelena Pistoni, Valentina Sancisi, Giulia Gobbi, Federica Torricelli, Benedetta Donati, Salvatore Ribisi, Mila Gugnoni, Alessia Ciarrocchi · 2019 · Molecular Cancer Research
  14. Performance Comparison of Computational Methods for the Prediction of the Function and Pathogenicity of Non-Coding Variants
    Zheng Wang, Guihu Zhao, Bin Li, Zhenghuan Fang, Qian Chen, Xiaomeng Wang, Tengfei Luo, Yijing Wang, Qiao Zhou, Kuokuo Li et al. · 2022 · Genomics Proteomics & Bioinformatics
  15. Large-scale DNA methylation expression analysis across 12 solid cancers reveals hypermethylation in the calcium-signaling pathway
    Xiaoxiong Wang, Fu‐Hui Xiao, Qi-Gang Li, Jia Liu, Yonghan He, Qing‐Peng Kong · 2017 · Oncotarget
  16. Structural Analysis Reveals Features of Ribosome Assembly Factor Nsa1/WDR74 Important for Localization and Interaction with Rix7/NVL2
    Yu‐Hua Lo, Erin M. Romes, Monica C. Pillon, Mack Sobhany, Robin Evans Stanley · 2017 · Structure
  17. Occurrence, functionality and abundance of the TERT promoter mutations
    Sivaramakrishna P. Rachakonda, Jörg D. Hoheisel, Rajiv Kumar · 2021 · International Journal of Cancer
  18. Comprehensive characterization of somatic variants associated with intronic polyadenylation in human cancers
    Zhaozhao Zhao, Qiushi Xu, Ran Wei, Leihuan Huang, Weixu Wang, Gang Wei, Ting Ni · 2021 · Nucleic Acids Research
  19. Role of Enhancers in Development and Diseases
    Shailendra Shanker Maurya · 2021 · Epigenomes
  20. The role of RNA binding proteins in hepatocellular carcinoma
    Kai Zhang, Anna E. Barry, Ryan J. Lamm, Keyur Patel, Michelle Schafer, Hien T. Dang · 2022 · Advanced Drug Delivery Reviews
  21. The pleiotropic role of non-coding genes in development and cancer
    Alessandra Pasut, Akinobu Matsumoto, John G. Clohessy, Pier Paolo Pandolfi · 2016 · Current Opinion in Cell Biology
  22. Altered TERT promoter and other genomic regulatory elements: occurrence and impact
    Barbara Heidenreich, Rajiv Kumar · 2017 · International Journal of Cancer
  23. Recurrent mutations at estrogen receptor binding sites alter chromatin topology and distal gene expression in breast cancer
    Jiekun Yang, Xiaolong Wei, Turan Tufan, Cem Kuscu, Hayrunnisa Unlu, Saadia Farooq, Elif Demirtas, Bryce M. Paschal, Mazhar Adli · 2018 · Genome biology
  24. High Prevalence of a Hotspot of Noncoding Somatic Mutations in Intron 6 of GPR126 in Bladder Cancer
    Simon Garinet, G. Pignot, Sophie Vacher, Constance Le Goux, Anne Schnitzler, Walid Chemlali, Nanor Sirab, Nicolas Barry Delongchamps, Marc Zerbib, Mathilde Sibony et al. · 2018 · Molecular Cancer Research
  25. Identification of recurrent noncoding mutations in B-cell lymphoma using capture Hi-C
    Alex J. Cornish, Phuc H. Hoang, Sara E. Dobbins, Philip Law, Daniel Chubb, Giulia Orlando, Richard S. Houlston · 2019 · Blood Advances
  26. Epigenomic Mapping and Effect Sizes of Noncoding Variants Associated with Psychotropic Drug Response
    Gerald A. Higgins, Ari Allyn-Feuer, Brian D Athey · 2015 · Pharmacogenomics
  27. Diagnostic Targeted Sequencing Panel for Hepatocellular Carcinoma Genomic Screening.
    V. Paradiso, A. Garofoli, N. Tosti, Manuela Lanzafame, Valeria Perrina, L. Quagliata, M. Matter, S. Wieland, M. Heim, S. Piscuoglio et al. · 2018 · Journal of Molecular Diagnostics
  28. Non-coding de novo mutations in chromatin interactions are implicated in autism spectrum disorder
    Il Bin Kim, Taeyeop Lee, Junehawk Lee, Jonghun Kim, Suho Lee, In Gyeong Koh, Jae Hyun Kim, Joon‐Yong An, Hyunseong Lee, Woo Kyeong Kim et al. · 2022 · Molecular Psychiatry
  29. Functional annotation of HOT regions in the human genome: implications for human disease and cancer
    Hao Li, Hebing Chen, Feng Liu, Chao Ren, Shengqi Wang, Xiaochen Bo, Wenjie Shu · 2015 · Scientific Reports
  30. Identification of High-Impact cis-Regulatory Mutations Using Transcription Factor Specific Random Forest Models
    Dmitry Svetlichnyy, Hana Imrichová, Mark W. E. J. Fiers, Zeynep Kalender Atak, Stein Aerts · 2015 · PLoS Computational Biology
  31. Coding and noncoding somatic mutations in candidate genes in basal cell carcinoma
    Maria Giovanna Maturo, P. Sivaramakrishna Rachakonda, Barbara Heidenreich, Cristina Pellegrini, Nalini Srinivas, Celia Requena, Carlos Serra-Guillén, B. Llombart, Onofre Sanmartín, Carlos Guillén et al. · 2020 · Scientific Reports
  32. Comprehensive fundamental somatic variant calling and quality management strategies for human cancer genomes
    Xiaoyu He, Shanyu Chen, Ruilin Li, Xinyin Han, Zhipeng He, Dan‐Yang Yuan, Shuying Zhang, Xiaohong Duan, Beifang Niu · 2020 · Briefings in Bioinformatics
  33. Genetic analysis of the CITED2 gene promoter in isolated and sporadic congenital ventricular septal defects
    Si‐qiang Zheng, Huanxin Chen, Xiao‐Cheng Liu, Qin Yang, Guo‐Wei He · 2021 · Journal of Cellular and Molecular Medicine
  34. Telomerase Upregulation Induces Progression of Mouse BrafV600E-Driven Thyroid Cancers and Triggers Nontelomeric Effects
    Iñigo Landa, Caitlin E.M. Thornton, Bin Xu, Jacob Haase, Gnana Prakasam Krishnamoorthy, Jingzhu Hao, Jeffrey A. Knauf, Zachary T. Herbert, Paula Martínez, Marı́a A. Blasco et al. · 2023 · Molecular Cancer Research
  35. Integrative whole-genome sequence analysis reveals roles of regulatory mutations in BCL6 and BCL2 in follicular lymphoma
    Kirill Batmanov, Wei J. Wang, Magnar Bjørås, Jan Delabie, Junbai Wang · 2017 · Scientific Reports
  36. Identifying DNase I hypersensitive sites as driver distal regulatory elements in breast cancer
    Matteo D’Antonio, Donate Weghorn, Agnieszka D’Antonio‐Chronowska, Florence Coulet, Katrina M. Olson, Christopher DeBoever, Frauke Drees, Angelo D. Arias, Hakan Alakus, Andrea L. Richardson et al. · 2017 · Nature Communications
  37. Genomic basis for RNA alterations revealed by whole-genome analyses of 27 cancer types
    PCAWG Transcriptome Core Group, Claudia Calabrese, Natalie R. Davidson, Nuno A. Fonseca, Yao He, André Kahles, Kjong-Van Lehmann, Fenglin Liu, Yuichi Shiraishi, Cameron M. Soulette et al. · 2017 · bioRxiv (Cold Spring Harbor Laboratory)
  38. Identification of variants of ISL1 gene promoter and cellular functions in isolated ventricular septal defects
    Si‐qiang Zheng, Huanxin Chen, Xiao‐Cheng Liu, Qin Yang, Guo‐Wei He · 2021 · American Journal of Physiology-Cell Physiology
  39. PanCancer analysis of somatic mutations in repetitive regions reveals recurrent mutations in snRNA U2
    Pablo Bousquets‐Muñoz, Ander Díaz‐Navarro, Ferran Nadeu, Ana S. Pitiot, Sara López-Tamargo, Shimin Shuai, Milagros Balbı́n, José M. C. Tubío, Sı́lvia Beà, José Ignacio Martín-Subero et al. · 2022 · npj Genomic Medicine
  40. The search for cis-regulatory driver mutations in cancer genomes
    Rebecca C. Poulos, Mathew A. Sloane, Luke B. Hesson, Jason W.H. Wong · 2015 · Oncotarget
  41. Clustered somatic mutations are frequent in transcription factor binding motifs within proximal promoter regions in melanoma and other cutaneous malignancies
    Andrew J. Colebatch, Leon Di Stefano, Stephen Q. Wong, Ross D. Hannan, Paul Waring, Alexander Dobrovic, Grant A. McArthur, Anthony T. Papenfuss · 2016 · Oncotarget
  42. Distribution of TERT promoter mutations in primary and metastatic melanomas in Austrian patients
    Richard Ofner, Cathrin Ritter, Barbara Heidenreich, Rajiv Kumar, Selma Ugurel, David Schrama, Jürgen Christian Becker · 2016 · Journal of Cancer Research and Clinical Oncology
  43. MEK inhibition remodels the active chromatin landscape and induces SOX10 genomic recruitment in BRAF(V600E) mutant melanoma cells
    NISC Comparative Sequencing Program, Temesgen Fufa, Laura L. Baxter, Julia C. Wedel, Derek E. Gildea, Stacie K. Loftus, William J. Pavan · 2019 · Epigenetics & Chromatin
  44. The transcription factor FLI1 promotes cancer progression by affecting cell cycle regulation
    Beiping Miao, Andrea S. Bauer, Katrin Hufnagel, Yenan Wu, Marija Trajkovic‐Arsic, Anna Chiara Pirona, Nathalia A. Giese, Jussi Taipale, Jens Thomas Siveke, Jörg D. Hoheisel et al. · 2019 · International Journal of Cancer
  45. Differential Allele-Specific Expression Uncovers Breast Cancer Genes Dysregulated by Cis Noncoding Mutations
    Pawel F. Przytycki, Mona Singh · 2020 · Cell Systems
  46. Thyroid transcription factor FOXE1 interacts with ETS factor ELK1 to co-regulate TERT
    Martyn Bullock, Grace Lim, Cheng Li, In Ho Choi, Shivansh Kochhar, Chris Liddle, Lei Zhang, Roderick John Clifton-Bligh · 2016 · Oncotarget
  47. The clinical applications of The Cancer Genome Atlas project for bladder cancer
    Chad J. Creighton · 2018 · Expert Review of Anticancer Therapy
  48. Noncoding RNA (ncRNA) Profile Association with Patient Outcome in Epithelial Ovarian Cancer Cases
    Douglas V.N.P. Oliveira, Kira Philipsen Prahm, Ib Jarle Christensen, Anker Hansen, Claus Kim Høgdall, Estrid Vilma Solyom Høgdall · 2020 · Reproductive Sciences
  49. Somatic Mutations Enriched in Cis -Regulatory Elements Affect Genes Involved in Embryonic Development and Immune System Response in Neuroblastoma
    Vito Alessandro Lasorsa, Annalaura Montella, Sueva Cantalupo, Matilde Tirelli, Carmen de Torres, Sanja Aveic, Gian Paolo Tonini, Achille Iolascon, Mario Capasso · 2022 · Cancer Research
  50. Privacy Challenges of Genomic Big Data
    Hong Shen, Jian Ma · 2017 · Advances in experimental medicine and biology
  51. Genome Sequencing and RNA-Motif Analysis Reveal Novel Damaging Noncoding Mutations in Human Tumors
    Babita Singh, Juan L. Trincado, PJ Tatlow, Stephen Piccolo, Eduardo Eyras · 2018 · Molecular Cancer Research
  52. Expression of hTERT in Oral Submucous Fibrosis and Oral Squamous Cell Carcinoma – an Immunohistochemical Analysis
    Lizbeth Raju K, Vanishri C. Haragannavar, Shankargouda Patil, Roopa S. Rao, Tejavathi Nagaraj, Dominic Augustine, Sowmya Samudrala Venkatesiah, Shwetha K Nambiar · 2019 · Pathology & Oncology Research
  53. Whole-Genome Sequencing of Finnish Type 1 Diabetic Siblings Discordant for Kidney Disease Reveals DNA Variants associated with Diabetic Nephropathy
    Jing Guo, Owen J. L. Rackham, Niina Sandholm, Bing He, Anne‐May Österholm, Erkka Valo, Valma Harjutsalo, Carol M. Forsblom, Iiro Toppila, Maija Parkkonen et al. · 2020 · Journal of the American Society of Nephrology
  54. Genomic Instability Signature of Palindromic Non-Coding Somatic Mutations in Bladder Cancer
    Sophie Vacher, Voreak Suybeng, Elodie Girard, Julien Masliah‐Planchon, Gregory J. Thomson, C. Goux, Simon Garinet, Anne Schnitzler, Walid Chemlali, Virginie Firlej et al. · 2020 · Cancers
  55. PLEKHS1: A new molecular marker predicting risk of progression of non‑muscle‑invasive bladder cancer
    G�raldine Pignot, C. Goux, Sophie Vacher, Anne Schnitzler, François Radvanyi, Yves Allory, Fran�ois Lallemand, Nicolas Barry Delongchamps, Marc Zerbib, Benoît Terris et al. · 2019 · Oncology Letters
  56. BayesPI-BAR: a new biophysical model for characterization of regulatory sequence variations
    Junbai Wang, Kirill Batmanov · 2015 · Nucleic Acids Research
  57. PIWI family proteins as prognostic markers in cancer: a systematic review and meta-analysis
    Alexios‐Fotios A. Mentis, Efthimios Dardiotis, Nicholas A. Romas, Athanasios G. Papavassiliou · 2019 · Cellular and Molecular Life Sciences
  58. Non-Coding Mutations in Urothelial Bladder Cancer: Biological and Clinical Relevance and Potential Utility as Biomarkers
    Ruhana R. Jeeta, Naheema S. Gordon, Laura A. Baxter, Anshita Goel, Boris Noyvert, Sascha Ott, Rebecca H. Boucher, Nada Humayun-Zakaria, Roland R. Arnold, Nicholas David James et al. · 2019 · Bladder Cancer
  59. Mosaicism in genodermatoses
    Shayan Cheraghlou, Young Hee Lim, Keith Adam Choate · 2020 · Clinics in Dermatology
  60. MutSpot: detection of non-coding mutation hotspots in cancer genomes
    Yu Amanda Guo, Mei Mei Chang, Anders J. Skanderup · 2020 · npj Genomic Medicine
  61. An Innovative Prognostic Model Based on Four Genes in Asian Patient with Gastric Cancer
    Jiahui Chen, Anqiang Wang, Guoqing Lyu, Kai Zhou, Ke Ji, Xin Ji, Tao Fu, Ji Zhang, 吴晓江, Zhaode Bu et al. · 2019 · Cancer Research and Treatment
  62. The head and neck cancer genome in the era of immunotherapy
    Neil Ari Wijetunga, Yao Yu, Luc G.T. Morris, Nancy Y. Lee, Nadeem Riaz · 2020 · Oral Oncology
  63. Systematic analysis of somatic mutations driving cancer: uncovering functional protein regions in disease development
    Bálint Mészáros, András Zeke, Attila Reményi, István Simon, Zsuzsanna Dosztányi · 2016 · Biology Direct
  64. Genome Stability
    Igor Kovalchuk · 2016 · Elsevier eBooks
  65. Screening of an Ethyl Methane Sulfonate Mutagenized Population of a Wheat Cultivar Susceptible to Fusarium Head Blight Identifies Resistant Variants
    Bhavit Chhabra, Lovepreet Singh, Sydney Wallace, Adam William Schoen, Yanhong Dong, Vijay Kumar Tiwari, Nidhi Rawat · 2021 · Plant Disease
  66. Lack of TERT Promoter Mutations in Human B-Cell Non-Hodgkin Lymphoma
    Gary Lam, Rena R. Xian, Yingying Li, Kathleen H. Burns, KAREN L. BEEMON · 2016 · Genes
  67. Detection of Aberrant TERT Promoter Methylation by Combined Bisulfite Restriction Enzyme Analysis for Cancer Diagnosis
    Seungjae Lee, Sumit Borah, Armita Bahrami · 2017 · Journal of Molecular Diagnostics
  68. pDriver : a novel method for unravelling personalized coding and miRNA cancer drivers
    Vu Pham, Lin Liu, Cameron P. Bracken, Thin Nguyen, Gregory J. Goodall, Jiuyong Li, Thuc Duy Le · 2021 · Bioinformatics
  69. Regulatory region mutations of TERT , PLEKHS1 and GPR126 genes as urinary biomarkers in upper tract urothelial carcinomas
    Xiangling Xing, Xiaotian Yuan, Tiantian Liu, Mingkai Dai, Yidong Fan, Cheng Liu, Klas Strååt, Magnus Björkholm, Dawei Xu · 2021 · Journal of Cancer
  70. Evaluation of gene expression of PLEKHS1, AADAC, and CDKN3 as novel genomic markers in gastric carcinoma
    Marwa Sayed Abdel-Tawab, Hanan Hassan Fouad, Asmaa M. Othman, Ragaey Ahmad Eid, Marwa Abdeltawab Mohammed, Ahmed Hassan, Hoda Ramadan Reyad · 2022 · PLoS ONE
  71. Influence of genetic polymorphism on transcriptional enhancer activity in the malaria vector Anopheles coluzzii
    Luisa Nardini, Inge Holm, Adrien Pain, Emmanuel Bischoff, Daryl M. Gohl, Soumanaba Zongo, Moussa Wamdaogo Guelbeogo, N’Falé Sagnon, Kenneth D. Vernick, Michelle M. Riehle · 2019 · Scientific Reports
  72. Telomere Maintenance in Pediatric Cancer
    Sandra Ackermann, Matthias Fischer · 2019 · International Journal of Molecular Sciences
  73. The role of noncoding mutations in blood cancers
    Sunniyat Rahman, Marc R. Mansour · 2019 · Disease Models & Mechanisms
  74. Cross-species oncogenomics using zebrafish models of cancer
    Richard Mark White · 2015 · Current Opinion in Genetics & Development
  75. TERRA Gene Expression in Gastric Cancer: Role of hTERT
    Sogand Vahidi, Ali Akbar Samadani · 2021 · Journal of Gastrointestinal Cancer
  76. PLEKHS1 drives PI3Ks and remodels pathway homeostasis in PTEN-null prostate
    Tamara A. M. Chessa, Piotr Jung, Arqum Anwar, Sabine Suire, Karen E. Anderson, David Barneda, Anna Kielkowska, Barzan A. Sadiq, Ieng Wai Lai, Sérgio Luís Felisbino et al. · 2023 · Molecular Cell
  77. CNCDatabase: a database of non-coding cancer drivers
    Eric Minwei Liu, Alexander Martinez‐Fundichely, Rajesh Bollapragada, Maurice Spiewack, Ekta Khurana · 2020 · Nucleic Acids Research
  78. Improving existing analysis pipeline to identify and analyze cancer driver genes using multi-omics data
    Quang‐Huy Nguyen, Duc‐Hau Le · 2020 · Scientific Reports
  79. Functional significance of novel variants of the MEF2C gene promoter in congenital ventricular septal defects
    Zhi‐Hua Zeng, Huanxin Chen, Xiao‐Cheng Liu, Qin Yang, Guo‐Wei He · 2022 · American Journal of Medical Genetics Part A
  80. Lip cancer and pre-cancerous lesions harbor TP53 mutations, exhibit allelic loss at 9p, 9q, and 17p, but no BRAFV600E mutations
    Gefter Thiago Batista Corrêa, Vanessa Fátima Bernardes, Sílvia Ferreira de Sousa, Marina Gonçalves Diniz, José Maria Porcaro Salles, Renan Pedra de Souza, Alfredo Maurício Batista de Paula, Ricardo Santiago Gomez, Carolina Cavaliéri Gomes · 2015 · Tumor Biology
  81. Disruption of a −35 kb Enhancer Impairs CTCF Binding and MLH1 Expression in Colorectal Cells
    Qing Liu, Julie A.I. Thoms, Andrea C. Nunez, Yizhou Huang, Kathy Knezevic, Deborah Packham, Rebecca C. Poulos, Rachel Williams, Dominik Beck, Nicholas John Hawkins et al. · 2018 · Clinical Cancer Research
  82. Multiplatform Molecular Profiling Reveals Epigenomic Intratumor Heterogeneity in Ependymoma
    S. Liu, S. Magill, H. Vasudevan, S. Hilz, Javier E. Villanueva-Meyer, S. Lastella, V. Daggubati, J. Spatz, A. Choudhury, Brent A. Orr et al. · 2020 · Cell Reports
  83. Plekhs1 and Prdx3 are candidate genes responsible for mild hyperglycemia associated with obesity in a new animal model of F344-fa-nidd6 rat
    Jun Kotoh, Daiki SASAKI, Kozo Matsumoto, Akihiko Maeda · 2016 · Journal of Veterinary Medical Science
  84. A comprehensive multicenter comparison of whole genome sequencing pipelines using a uniform tumor-normal sample pair
    Ivo Buchhalter, Barbara Hutter, Tyler Alioto, Timothy A. Beck, Paul Christopher Boutros, Benedikt Brors, Adam P. Butler, Sasithorn Chotewutmontri, Robert Edward Denroche, Sophia V. Derdak et al. · 2014 · bioRxiv (Cold Spring Harbor Laboratory)
  85. Widespread perturbation of ETS factor binding sites in cancer
    Sebastian Carrasco Pro, H. Hook, D. Bray, D. Berenzy, Devlin C. Moyer, Meimei Yin, A. Labadorf, R. Tewhey, T. Siggers, J. F. Fuxman Bass · 2022 · bioRxiv
  86. Accurate Detection of Urothelial Bladder Cancer Using Targeted Deep Sequencing of Urine DNA
    Dongin Lee, Wookjae Lee, Hwang‐Phill Kim, Myong Kim, Hyun Kyu Ahn, Duhee Bang, Kwang Hyun Kim · 2023 · Cancers
  87. Mapping and making sense of non-coding mutations in the genome.
    Jiekun Yang, Mazhar Adli · 2019 · Cancer Research
  88. Recurrent Noncoding Mutations in Skin Cancers: UV Damage Susceptibility or Repair Inhibition as Primary Driver?
    Steven A. Roberts, Alexander J. Brown, John J. Wyrick · 2019 · BioEssays
  89. Fusion transcripts and their genomic breakpoints in polyadenylated and ribosomal RNA–minus RNA sequencing data
    Youri Hoogstrate, Malgorzata A. Komor, René Böttcher, Job van Riet, Harmen J.G. van de Werken, Stef van Lieshout, Ralf Hoffmann, Evert van den Broek, Anne S. Bolijn, Natasja F. J. Dits et al. · 2021 · GigaScience
  90. Cis-regulatory mutations associate with transcriptional and post-transcriptional deregulation of gene regulatory programs in cancers
    Jaime Abraham Castro-Mondragon, Miriam R. R. Aure, Ole Christian Lingjærde, Anita Langerød, John W.M. Martens, Anne‐Lise Børresen‐Dale, Vessela Nedelcheva Kristensen, Anthony Mathelier · 2022 · Nucleic Acids Research
  91. Properties of non-coding mutation hotspots as urinary biomarkers for bladder cancer detection
    Laura A. Baxter, Naheema S. Gordon, Sascha Ott, Jiangtao Wang, Prashant Patel, A. Goel, Kim Piechocki, Lee Silcock, Chris Sale, Maurice Petrus Zeegers et al. · 2023 · Scientific Reports
  92. Long-range gene regulation and novel therapeutic applications
    Anita van den Heuvel, Ralph Stadhouders, Charlotte Andrieu‐Soler, Frank G. Grosveld, Éric Soler · 2015 · Blood
  93. Identification of cis-regulatory mutations generating de novo edges in personalized cancer gene regulatory networks
    Zeynep Kalender Atak, Hana Imrichová, Dmitry Svetlichnyy, Gert J. Hulselmans, Valerie Christiaens, Joke Reumers, Hugo Ceulemans, Stein Aerts · 2017 · Genome Medicine
  94. Differences of Variable Number Tandem Repeats in XRCC5 Promoter Are Associated with Increased or Decreased Risk of Breast Cancer in BRCA Gene Mutation Carriers
    Jian Cui, Jiangtao Luo, Yeong C. Kim, Carrie Snyder, Dina Becirovic, Bradley M. Downs, Henry T. Lynch, San Ming Wang · 2016 · Frontiers in Oncology
  95. Less is more in the hunt for driver mutations
    Sushant Kumar, Mark Gerstein · 2017 · Nature
  96. Whole genome sequencing and its applications in medical genetics
    Jiaxin Wu, Mengmeng Wu, Ting Chen, Rui Jiang · 2016 · Quantitative Biology
  97. SDHD Promoter Mutations Ablate GABP Transcription Factor Binding in Melanoma
    Tongwu Zhang, Mai Xu, Matthew M. Makowski, Christine Lee, Michael A. Kovacs, Jun Fang, Esther Willems, Jeffrey M. Trent, Nicholas K. Hayward, Michiel Vermeulen et al. · 2017 · Cancer Research
  98. Science belongs to no one—and to everyone
    Björn L.D.M. Brücher · 2017 · 4open
  99. Field-effect-informed urine liquid biopsy for bladder cancer
    William T. Shi, Kevin J. Liu, Mohammad Shahrokh Esfahani, Kathleen E. Mach, Nick A. Phillips, Diego Almanza, Ravi K. Bajpai, Joseph G. Schroers‐Martin, Ludimila Trabanino, Timothy Jiyong Lee et al. · 2026 · Cell
  100. Analysis of SDHD promoter mutations in various types of melanoma
    Simone L. Scholz, S. Horn, Rajmohan Murali, Inga Möller, A. Sucker, W. Sondermann, M. Stiller, B. Schilling, E. Livingstone, L. Zimmer et al. · 2015 · OncoTarget